Literature DB >> 10412898

Valproate metabolites in the rat brain--regional distribution in various brain areas.

J Darius1, F P Meyer, E Bergsträsser, E Ebermann, K Andreas.   

Abstract

To investigate the regional distribution of valproic acid (VPA) and 10 of its metabolites in the rat brain, the animals were treated with 300 mg/kg/day VPA i.p. on a 3 times daily dose regimen for 5 days, and the concentrations of the compounds in serum and 15 brain regions were measured. 2-(n-propyl)-(Z)-2-pentenoic acid [(Z)-2-en], a VPA metabolite expected to possess neurotoxic potency in humans, was determined in brain tissue for the first time. The brain/serum concentration ratio of (Z)-2-en was found to be about 14-fold higher than the ratio for its (E)-isomer, thereby demonstrating the influence of the double-bond configuration in the unsaturated metabolites on their ability to penetrate into the central nervous system. The concentrations of VPA and its metabolites in the brain regions were compared to c(hom), the calculated concentration for an assumed homogeneous distribution. The parent drug and its metabolites exhibited individual distribution patterns with varying degrees of inhomogeneity. Elevated metabolite concentrations were found especially in the motorium and the medulla oblongata. Decreased concentrations of VPA and several metabolites were found in the visual cortex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412898     DOI: 10.1007/BF03190017

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  20 in total

1.  Distribution of valproate across the interface between blood and cerebrospinal fluid.

Authors:  H H Frey; W Löscher
Journal:  Neuropharmacology       Date:  1978-08       Impact factor: 5.250

2.  Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.

Authors:  W Löscher; J E Fisher; H Nau; D Hönack
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

3.  A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.

Authors:  A Rohlfs; C Rundfeldt; R Koch; W Löscher
Journal:  J Pharmacol Exp Ther       Date:  1996-06       Impact factor: 4.030

4.  Anticonvulsant and neurotoxic activities of twelve analogues of valproic acid.

Authors:  M M Elmazar; R S Hauck; H Nau
Journal:  J Pharm Sci       Date:  1993-12       Impact factor: 3.534

5.  On-column gas chromatographic-mass spectrometric assay for metabolic profiling of valproate in brain tissue and serum.

Authors:  J Darius
Journal:  J Chromatogr B Biomed Appl       Date:  1996-06-28

6.  Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles.

Authors:  F S Abbott; A A Acheampong
Journal:  Neuropharmacology       Date:  1988-03       Impact factor: 5.250

7.  Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.

Authors:  K D Adkison; D D Shen
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

8.  Structure-activity relationships of unsaturated analogues of valproic acid.

Authors:  J Palaty; F S Abbott
Journal:  J Med Chem       Date:  1995-08-18       Impact factor: 7.446

9.  Distribution of unsaturated metabolites of valproate in human and rat brain--pharmacologic relevance?

Authors:  K D Adkison; G A Ojemann; R L Rapport; R L Dills; D D Shen
Journal:  Epilepsia       Date:  1995-08       Impact factor: 5.864

10.  A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group.

Authors:  A Richens; D L Davidson; N E Cartlidge; D J Easter
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

View more
  1 in total

1.  Valproic acid inhibits neural progenitor cell death by activation of NF-κB signaling pathway and up-regulation of Bcl-XL.

Authors:  Hyo Sang Go; Jung Eun Seo; Ki Chan Kim; So Min Han; Pitna Kim; Young Sun Kang; Seol Heui Han; Chan Young Shin; Kwang Ho Ko
Journal:  J Biomed Sci       Date:  2011-07-04       Impact factor: 8.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.